DiaMedica Therapeutics Inc Cash Flow-to-Debt Ratio
DiaMedica Therapeutics Inc cash flow-to-debt ratio. DiaMedica Therapeutics Inc (DMAC) has a Cash Flow-to-Debt Ratio of -1.55x as of March 2026, meaning its operating cash flow of $-9.08 Million could theoretically repay -2% of its total liabilities ($5.84 Million) in one year. See DMAC FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of DiaMedica Therapeutics Inc (2004–2025)
Cash flow-to-debt ratio of DiaMedica Therapeutics Inc from 2004 to 2025. Historical debt coverage capacity for DiaMedica Therapeutics Inc across 22 annual periods. Check DMAC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
DiaMedica Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2004–2025)
DiaMedica Therapeutics Inc cash flow-to-debt ratio by year from 2004 to 2025. Year-by-year debt coverage analysis for DiaMedica Therapeutics Inc. For the full cash flow conversion analysis, see DMAC operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.53x | $-29.06 Million | $5.26 Million | ▼ -40.8% |
| 2024 | -3.92x | $-22.08 Million | $5.63 Million | ▲ +35.0% |
| 2023 | -6.04x | $-18.73 Million | $3.10 Million | ▼ -34.6% |
| 2022 | -4.48x | $-11.51 Million | $2.57 Million | ▲ +44.1% |
| 2021 | -8.02x | $-12.25 Million | $1.53 Million | ▼ -81.8% |
| 2020 | -4.41x | $-9.19 Million | $2.08 Million | ▲ +30.4% |
| 2019 | -6.34x | $-9.10 Million | $1.44 Million | ▼ -46.2% |
| 2018 | -4.33x | $-5.70 Million | $1.31 Million | ▼ -11.5% |
| 2017 | -3.89x | $-3.90 Million | $1.00 Million | ▲ +19.4% |
| 2016 | -4.82x | $-3.02 Million | $626.97K | ▼ -412.5% |
| 2015 | -0.94x | $-1.37 Million | $1.45 Million | ▲ +54.6% |
| 2014 | -2.07x | $-3.76 Million | $1.81 Million | ▲ +42.5% |
| 2013 | -3.61x | $-5.50 Million | $1.52 Million | ▼ -4.2% |
| 2012 | -3.47x | $-5.48 Million | $1.58 Million | ▲ +63.2% |
| 2011 | -9.42x | $-3.44 Million | $364.56K | ▼ -119.7% |
| 2010 | -4.29x | $-2.38 Million | $554.10K | ▲ +60.5% |
| 2009 | -10.85x | $-2.15 Million | $197.87K | ▼ -61.3% |
| 2008 | -6.73x | $-1.47 Million | $218.01K | ▼ -51.0% |
| 2007 | -4.45x | $-1.21 Million | $272.38K | ▲ +70.4% |
| 2006 | -15.04x | $-801.16K | $53.27K | ▼ -2.2% |
| 2005 | -14.71x | $-831.17K | $56.49K | ▼ -18803.4% |
| 2004 | -0.08x | $-99.35K | $1.28 Million | — |